Medical Information
In order to provide you with relevant and meaningful content we need to know more about you.
Please choose the category that best describes you.
This content is intended for U.S. Healthcare Professionals. Would you like to proceed?
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.
Propofol Injectable Emulsion, USP is available in single-patient use vials as follows:
1 g of propofol per 100 mL of an oil-in-water emulsion (10 mg per mL), in a 100 mL vial
200 mg of propofol per 20 mL of an oil-in-water emulsion (10 mg per mL), in a 20 mL vial
500 mg of propofol per 50 mL of an oil-in-water emulsion (10 mg per mL), in a 50 mL vial
To report an adverse event related to Pfizer-BioNTech COVID-19 Vaccine (also known as COMIRNATY®, COVID-19 mRNA, Vaccine BNT162b2 or BNT162) or Pfizer COVID-19 Treatment (also known as PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets)), and you are not part of a clinical trial* for this product, click the link below to submit your information:
*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.
If you cannot use the above website or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at